GUÍA TÉCNICA G-BIOF 02: - Instituto de Salud Pública de Chile

Kortejärvi, M. Yliperttula, M., Dressman, J. B., Junginger, H. E., Midha,
K. K., Shah, V. P., Barends, D. M. Biowaiver Monographs for Immediate
Release Solid Oral Dosage Forms: Ranitidine Hydrochloride. J. Pharm.
Sci. 94 (8), 1617 – 1625, 2005
Le Cluyse E. and Sutton, S. In vitro models for selection of development
candidates. Permeability Studies to defined mechanisms of absorption
enhancement. Adv. Drug Del. Rev., 23:163-183, 1997
Lentz, K. A. Hayashi, J. Lucisano, L. J. Polli; J. E. Development of a
more rapid, reduced serum culture system for caco–2 monolayers and
application to the biopharmaceutics classification system. Int. J. Pharm.
200, 41 – 51, 2002.
Liebenberg W. y cols. Identification of the Mebendazole Polymorphic
Form present in Raw Materials and Tablets Available in South Africa.
Drug Dev Ind Pharm 24 (5) 485-488, 1998
Lindenberg, M. Koop, S. Dressman, J. B. Classification of orally
administered drugs on the World Health Organization Model list of
Essential Medicines according to the biopharmaceutics classification
system. Eur. J. Pharm. Biopharm., 58, 265 – 278, 2004
Löbenberg, R. Amidon, G. L. Modern bioavailability, bioequivalence and
biopharmaceutics classification system. New scientific approaches to
international regulatory standards. Eur. J. Pharm. Biopharm. 50, 3 – 12,
2000
NIHS, 1997. Guideline for bioequivalence Studies of Generic Products.
National Institute of Health Sciences, Japan,
http://www.nihs.go.jp/drug/be-guide(e)/generic/be97E.html.
Av. Marathón 1000 – Ñuñoa – Casilla 48 – Santiago – Teléfono: 350 74 77 – Código Postal: 7780050 – www.ispch.cl
G-BIOF-02
59